BAJAJ FINANCE LIMITED vs Biogen Pharmachem Industries Ltd
A side-by-side comparison of BAJAJ FINANCE LIMITED (BAJFINANCE) and Biogen Pharmachem Industries Ltd (BIOGENPHARMACHEMLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, BAJAJ FINANCE LIMITED leads BAJFINANCE vs BIOGENPHARMACHEMLTD on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability40
- Growth01
- Size & financial health31
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
BAJFINANCE takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
BIOGENPHARMACHEMLTD takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
BAJFINANCE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 34.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 18.6%", "Company's median sales growth is 29.4% of last 10 years"]
- − ["Stock is trading at 5.89 times its book value", "Company has low interest coverage ratio.", "Company might be capitalizing the interest cost"]
- + ["Company is almost debt free.", "Stock is trading at 0.30 times its book value"]
- − ["Company has low interest coverage ratio.", "Company has a low return on equity of 1.11% over last 3 years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.